Synthesis of N'-(Quinazolin-4-yl)isonicotinohydrazides and their biological screening, docking and ADME studies

Arabian Journal of Chemistry - Tập 13 - Trang 1986-2000 - 2020
Kinjal D. Patel1, Rajesh H. Vekariya1, Neelam P. Prajapati1, Dhaval B. Patel1, Hitesh D. Patel1, Tauhid Shaikh1, Dhanji P. Rajani2, Smita Rajani2, Naumita S. Shah3, Devendrasinh Jhala3
1Department of Chemistry, School of Sciences, Gujarat University, Navarangpura, Ahmedabad, Gujarat, India
2Microcare Laboratory and TRC, Surat, India
3Department of Zoology, School of Sciences, Gujarat University, Navarangpura, Ahmedabad, Gujarat, India

Tài liệu tham khảo

Divatia, 2019, Novel thiosemicarbazone derivatives containing benzimidazole moiety: green synthesis and anti-malarial activity, Arab. J. Chem., 12, 1641, 10.1016/j.arabjc.2014.09.007 Duffy, 2000, Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water, J. Am. Chem. Soc., 122, 2878, 10.1021/ja993663t El-Azab, 2010, Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docki ng study, Euro. J. Med. Chem., 45, 4188, 10.1016/j.ejmech.2010.06.013 Gomez, 2013, Recent developments on antimicrobial quinoline chemistry, Microb. Pathogens Strat. Combat. Them: Sci., Tech. Edu., 666 http://en.Wikipedia.org/wiki/Alfuzosin (excess on: 23rd May 2017). http://en.Wikipedia.org/wiki/Doxazosin (excess on: 23rd May 2017). http://en.Wikipedia.org/wiki/Terazosin (excess on: 23rd May 2017). Ioakimidis, 2008, Benchmarking the reliability of QikProp. Correlation between Experimental and Predicted Values, QSAR Comb. Sci., 27, 445, 10.1002/qsar.200730051 Jiang, 2016, Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands, Eur. J. Med. Chem., 122, 264, 10.1016/j.ejmech.2016.06.040 Johnsson, 1995, Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis, J. Am. Chem. Soc., 117, 5009, 10.1021/ja00122a038 Kumar, 2011, Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one, Euro. J. Med. Chem., 46, 1006, 10.1016/j.ejmech.2011.01.009 López-Gresa, 2005, Circumdatin H, a new inhibitor of mitochondrial NADH oxidase, from Aspergillus ochraceus, J. Antibiot., 58, 416, 10.1038/ja.2005.54 Lu, 2004, Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat, J. Med. Chem., 47, 6104, 10.1021/jm0306529 Madhavi, 2017, Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents, Saudi Pharm. J., 25, 275, 10.1016/j.jsps.2016.06.005 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immuno Methods., 65, 55, 10.1016/0022-1759(83)90303-4 Michael, 2008, Quinoline, quinazoline and acridone alkaloids, Nat. Prod. Rep., 25, 166, 10.1039/B612168N Michael, 2007, Quinoline, quinazoline and acridone alkaloids, Nat. Prod. Rep., 24, 223, 10.1039/b509528j News for the research community of the u. s. department of veterans affairs, April 2007. VA Res. Curr. 1–8. Patel, 2013, Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction, Med. Chem. Res., 22, 367, 10.1007/s00044-012-0041-y Patel, 2015, Synthesis, biological evaluation and 3D QSAR study of 2,4- disubstituted quinolines as anti-tuberculosis agents, Euro. J. Med. Chem., 93, 511, 10.1016/j.ejmech.2015.02.034 Pei-lan, H., Wei, T., Fei-hong, J., Jian-ping, Z., Bo, C., De-wen, L., Xian-kun, T., You-hong, H., 2012. Use of quinazoline compounds in preparation of drug for resisting flaviviridae viruses. CN 102552271 A. Pore, 2015, Design and synthesis of 11a-substituted bile acid derivatives as potential anti-tuberculosis agents, Bioorg. Med. Chem., 25, 4185, 10.1016/j.bmcl.2015.08.006 Prajapati, 2014, Synthesis and in vitro antibacterial and antifungal evaluation of quinoline analogue azetidin and thiazolidin derivatives, Int. Lett. Chem. Phys. Astron., 195, 10.18052/www.scipress.com/ILCPA.39.195 QikProp, Technical Information (2.1). Rahaek, 1998, Circumdatins D, E, and F: further fungal benzodiazepine analogues from Aspergillus ochraceus, J. Nat. Prod., 62, 904, 10.1021/np980495u Rahaek, 1999, Circumdatin A, B, and C: three new benzodiazepine alkaloids isolated from a culture of the fungus aspergillus ochraceus, J. Org. Chem., 64, 1689, 10.1021/jo981536u Sah, P.P., Peoples, S.A., 1954, Isonicotinyl hydrazones as antitubercular agents and derivatives for identification of aldehydes and ketones, J. Am. Pharm. Assoc. Am. Pharm. Assoc., 43, 513, 10.1002/jps.3030430902 Selvam, 2011, Quinazoline marketed drugs – a review, Res. Pharm., 1, 1 Shah, 2016, Design, synthesis and characterization of quinoline–pyrimidine linked calix[4]arene scaffolds as anti-malarial agents, J. Incl. Phenom. Macrocycl. Chem., 84, 173, 10.1007/s10847-015-0581-0 Sharma, 2012, Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparum transketolase and β-hematin inhibitors, Med. Chem. Commun., 3, 71, 10.1039/C1MD00188D Shi, 2014, Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2, Bioorg. Med. Chem., 22, 4735, 10.1016/j.bmc.2014.07.008 Tseng, 2010, Total synthesis of asperlicin C, circumdatin F, demethylbenzomalvin A, demethoxycircumdatin H, sclerotigenin, and other fused quinazolinones, Org. Biomol. Chem., 8, 419, 10.1039/B910545J Viegas-Junior, 2007, Molecular hybridization: a useful tool in the design of new drug prototypes, Curr. Microwave Chem., 14, 1829, 10.2174/092986707781058805 Yamada, 2008, Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats, Horm. Metab. Res., 40, 539, 10.1055/s-2008-1076699 Zhu, 2009, Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents, Bioorg. Med. Chem., 17, 4496, 10.1016/j.bmc.2009.05.011